Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Aug 14, 2019; 25(30): 4235-4245
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4235
Table 3 Predictors of escalation to immunomodulators among mild Crohn’s patients
Univariate
P value
Hazard ratio (95%CI)
Age at diagnosis1.24 (0.97-1.59)0.09
Gender (female vs male)0.67 (0.15-3.00)0.60
Paris location at diagnosis
Lower 1/3 of ileum +/- base of cecum1.29 (0.30-5.66)0.73
Colon only0.96 (0.19-4.99)0.96
Ileum and colon0.50 (0.10-2.53)0.40
Upper GI proximal to Ligament of Treitz1.00 (0.19-5.17)1.00
Distal to Ligament of Treitz to proximal ileum5.46 (0.61-49.27)0.13
Any steroids in the first 2 yr1.26 (0.30-5.35)0.75
Any steroids after the first 2 yr12.1 (1.4-102.7)0.02
Complications5.6 (1.3-24.9)0.02